Water
Evaluate moisture exposure and the needs of the active-containing phase.
Advanced gummy delivery technology for ingredients that don't normally play well with gummies.
Active-Saver® is Global Products Group's proprietary gummy delivery technology platform designed to create a more controlled environment for sensitive active ingredients.

Engineer the gummy around the needs of the active. A specialized environment creates more options for addressing formulation challenges.
Evaluate moisture exposure and the needs of the active-containing phase.
Explore formulation approaches for oxidation-sensitive ingredients.
Consider ingredient sensitivity throughout development and processing.
Evaluate light sensitivity alongside formulation and packaging choices.
Explore physical separation where ingredients are difficult to formulate together.
More than a center-filled gummy: a multiphase architecture allows the active-containing phase to be formulated separately from the surrounding gummy matrix.
The surrounding gummy matrix provides the consumer-facing format and is developed around the needs of the overall system.
The relationship between phases is considered as part of the complete delivery architecture.
A distinct phase creates formulation options for sensitive actives, including ingredients suited to lipid-based environments.
Conceptual architecture. Composition and performance depend on the individual application and testing.
Kaneka Ubiquinol® is a proof-of-concept application for Active-Saver®.
It demonstrates the platform's ingredient-first approach: develop the active environment, then engineer the gummy around it. Explore the dedicated Ubiquinol FAQ for application-specific information.
Ubiquinol-specific findings do not establish performance for other ingredients.
Explore the Ubiquinol Case Study
Bring us the ingredient and the challenge. These categories are starting points for evaluation.
Evaluate approaches for ingredients challenged by oxygen exposure.
Explore an active environment with different formulation needs from the gummy matrix.
Consider sensitivities across formulation, processing, and packaging.
Explore specialized active phases suited to lipid-based systems.
Assess feasibility through ingredient-specific development and analytical evaluation.
Evaluate multiphase options for ingredient-interaction challenges.
Not every ingredient will be compatible with Active-Saver®. Each application requires formulation development, analytical evaluation, and appropriate stability testing.
Define the active, target dose, sensitivities, and product goals.
Explore the phase composition and conditions suited to the ingredient.
Develop the relationship between the active phase, interface, and gummy matrix.
Use analytical evaluation and appropriate stability testing to assess the application.
Plan manufacturing and packaging around the validated product requirements.
Start with the needs of the active ingredient.
Formulate distinct environments within one delivery format.
Evaluate candidates that challenge conventional gummy formulation.
Develop an approachable gummy experience with taste and texture in mind.
Connect product development with GPG's manufacturing capabilities.
Build a clear product narrative around a thoughtful delivery approach.
It is Global Products Group's proprietary gummy delivery technology platform, designed to create a more controlled environment for sensitive active ingredients.
A multiphase approach allows the active-containing phase to be formulated separately from the surrounding gummy matrix.
No. Kaneka Ubiquinol® is a proof-of-concept application. Other ingredients require their own development and evaluation.
Candidates may include oxidation-, moisture-, heat-, and light-sensitive actives, oil-soluble ingredients, and ingredients requiring physical separation.
Lipid-based active phases can be explored. Suitability depends on the ingredient and the complete formulation.
They may be considered for feasibility evaluation. Compatibility, viability, and stability must be established for the specific strain and finished product.
No. Each application requires analytical evaluation and appropriate stability testing. Performance and shelf life are product-specific.
Contact GPG to discuss formulation goals, development requirements, and a potential partner-brand project.
Challenge us.
Tell us what you are working with—and what you want to make possible.